{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,7]],"date-time":"2024-09-07T22:55:22Z","timestamp":1725749722602},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2006,5,1]],"date-time":"2006-05-01T00:00:00Z","timestamp":1146441600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2006,5,1]],"date-time":"2006-05-01T00:00:00Z","timestamp":1146441600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Treat Options Neurol"],"published-print":{"date-parts":[[2006,5]]},"DOI":"10.1007\/s11940-006-0010-1","type":"journal-article","created":{"date-parts":[[2007,6,5]],"date-time":"2007-06-05T20:17:51Z","timestamp":1181074671000},"page":"193-201","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Central nervous system infections in transplantation"],"prefix":"10.1007","volume":"8","author":[{"given":"Todd","family":"Czartoski","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"10_CR1","unstructured":"National Marrow Donor Program: 2004 Statistics. http:\/\/www.marrow.org. Accessed December 15, 2005."},{"key":"10_CR2","unstructured":"Scientific Registry of Transplant Recipients 2004 Annual Report. http:\/\/www.ustransplant.org. Accessed December 15, 2005."},{"key":"10_CR3","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1212\/WNL.46.4.1004","volume":"46","author":"F Graus","year":"1996","unstructured":"Graus F, Saiz A, Sierra J, et al.: Neurologic complications of autologous and allogenic bone marrow transplantation in patients with leukemia: a comparative study. Neurology 1996, 46:1004\u20131009.","journal-title":"Neurology"},{"key":"10_CR4","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1055\/s-2004-861537","volume":"24","author":"A Saiz","year":"2004","unstructured":"Saiz A, Graus F: Neurological complications of hematopoietic cell transplantation. Semin Neurol 2004, 24:427\u2013434. This review describes neurologic complications encountered at each stage of transplantation.","journal-title":"Semin Neurol"},{"key":"10_CR5","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1212\/01.WNL.0000046522.38465.79","volume":"60","author":"P Sostak","year":"2003","unstructured":"Sostak P, Padovan CS, Yousry TA, et al.: Prospective evaluation of neurological complications after allogenic bone marrow transplantation. Neurology 2003, 60:842\u2013848. Seventy-one patients were followed prospectively for an average of 14 months after HCT. Forty-six developed neurologic complications, eight of which were infections.","journal-title":"Neurology"},{"key":"10_CR6","first-page":"1135","volume":"18","author":"D Gallardo","year":"1996","unstructured":"Gallardo D, Ferra C, Berlanga JJ, et al.: Neurologic complications after allogeneic bone marrow transplantation. Bone Marrow Transplant 1996, 18:1135\u20131139.","journal-title":"Bone Marrow Transplant"},{"key":"10_CR7","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1034\/j.1399-3062.2000.020302.x","volume":"2","author":"N Singh","year":"2000","unstructured":"Singh N, Husain S: Infections of the central nervous system in transplant recipients. Transpl Infect Dis 2000, 2:101\u2013111. This excellent review addresses CNS infections in SOT and HCT recipients.","journal-title":"Transpl Infect Dis"},{"key":"10_CR8","first-page":"730","volume-title":"Transplant Infections","author":"KL Roos","year":"2003","unstructured":"Roos KL: Central nervous system infections after hemopoietic stem cell or solid organ transplantation. In Transplant Infections, edn 2. Edited by Bowden RA, Ljungman P, Paya CV. Philadelphia, PA: Lippincott Williams & Wilkins; 2003:730. This chapter describes common CNS infections and their treatment in SOT and HCT.","edition":"edn 2"},{"key":"10_CR9","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1056\/NEJM199806113382407","volume":"338","author":"JA Fishman","year":"1998","unstructured":"Fishman JA, Rubin RH: Infection in organ-transplant recipients. N Engl J Med 1998, 338:1741\u20131751.","journal-title":"N Engl J Med"},{"key":"10_CR10","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1128\/CMR.10.1.86","volume":"10","author":"R Patel","year":"1997","unstructured":"Patel R, Paya CV: Infections in solid-organ transplant recipients. Clin Microbiol Rev 1997, 10:86\u2013124.","journal-title":"Clin Microbiol Rev"},{"key":"10_CR11","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1086\/322642","volume":"33","author":"DM Zerr","year":"2001","unstructured":"Zerr DM, Gooley TA, Yeung L, et al.: Human herpesvirus 6 reactivation and encephalitis in allogeneic bone marrow transplant recipients. Clin Infect Dis 2001, 33:763\u2013771. This retrospective analysis looked at characteristics of patients developing HHV6 encephalitis.","journal-title":"Clin Infect Dis"},{"key":"10_CR12","doi-asserted-by":"publisher","first-page":"474","DOI":"10.3109\/13550289809113492","volume":"4","author":"DW Kimberlin","year":"1998","unstructured":"Kimberlin DW, Whitley RJ: Human herpesvirus-6: neurologic implications of a newly-described viral pathogen. J Neurovirol 1998, 4:474\u2013485.","journal-title":"J Neurovirol"},{"key":"10_CR13","doi-asserted-by":"publisher","first-page":"2474","DOI":"10.1097\/00007890-200006270-00002","volume":"69","author":"N Singh","year":"2000","unstructured":"Singh N, Paterson DL: Encephalitis caused by human herpesvirus-6 in transplant recipients: relevance of a novel neurotropic virus. Transplantation 2000, 69:2474\u20132479.","journal-title":"Transplantation"},{"key":"10_CR14","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1086\/322691","volume":"33","author":"MT Caserta","year":"2001","unstructured":"Caserta MT, Mock DJ, Dewhurst S: Human herpesvirus 6. Clin Infect Dis 2001, 33:829\u2013833.","journal-title":"Clin Infect Dis"},{"key":"10_CR15","doi-asserted-by":"publisher","first-page":"1596","DOI":"10.1097\/00007890-199812270-00005","volume":"66","author":"CA Bonham","year":"1988","unstructured":"BonhamCA, Dominguez EA, Fukui MB, et al.: Central nervous system lesions in liver transplant recipients: prospective assessment of indications for biopsy and implications for management. Transplantation 1988, 66:1596\u20131604. This prospective study of 1730 liver transplant recipients over 4 years found that 60 had a CNS mass lesion. Eleven of 60 were infections (all fungal). Eight of 11 fungal infections had concurrent pulmonary disease.","journal-title":"Transplantation"},{"key":"10_CR16","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1086\/339202","volume":"34","author":"KA Marr","year":"2002","unstructured":"Marr KA, Carter RA, Crippa F, et al.: Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients. Clin Infect Dis 2002, 34:909\u2013917. This retrospective study details risk factors and prognosis related to mold infections in HCT recipients.","journal-title":"Clin Infect Dis"},{"key":"10_CR17","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1097\/00001432-200312000-00015","volume":"16","author":"M Nucci","year":"2003","unstructured":"Nucci M: Emerging moulds: Fusarium, Scedosporium and Zygomycetes in transplant recipients. Curr Opin Infect Dis 2003, 16:607\u2013612.","journal-title":"Curr Opin Infect Dis"},{"key":"10_CR18","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1086\/375822","volume":"37","author":"S Husain","year":"2003","unstructured":"Husain S, Alexander BD, Munoz P, et al.: Opportunistic mycelial fungal infections in organ transplant recipients: emerging importance of non-Aspergillus mycelial fungi. Clin Infect Dis 2003, 37:221\u2013229.","journal-title":"Clin Infect Dis"},{"key":"10_CR19","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1128\/CMR.18.3.556-569.2005","volume":"18","author":"B Spellberg","year":"2005","unstructured":"Spellberg B, Edwards JJr, Ibrahim A: Novel perspectives on mucormycosis: pathophysiology, presentation, and management. Clin Microbiol Rev 2005, 18:556\u2013569.","journal-title":"Clin Microbiol Rev"},{"key":"10_CR20","doi-asserted-by":"publisher","first-page":"2593","DOI":"10.2146\/ajhp050188","volume":"62","author":"J Brown","year":"2005","unstructured":"Brown J: Zygomycosis: an emerging fungal infection. Am J Health Syst Pharm 2005, 62:2593\u20132596.","journal-title":"Am J Health Syst Pharm"},{"key":"10_CR21","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/j.bbmt.2004.05.004","volume":"10","author":"Y Kishi","year":"2004","unstructured":"Kishi Y, Miyakoshi S, Kami M, et al.: Early central nervous system complications after reduced-intensity stem cell transplantation. Biol Blood Marrow Transplant 2004, 10:561\u2013568.","journal-title":"Biol Blood Marrow Transplant"},{"key":"10_CR22","doi-asserted-by":"publisher","first-page":"1978","DOI":"10.1182\/blood.V99.6.1978","volume":"99","author":"C Junghanss","year":"2002","unstructured":"Junghanss C, Boeckh M, Carter RA, et al.: Incidence and outcome of cytomegalovirus infections following nonmyeloablative compared with myeloablative allogeneic stem cell transplantation, a matched control study. Blood 2002, 99:1978\u20131985.","journal-title":"Blood"},{"key":"10_CR23","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1053\/bbmt.2002.v8.pm12374456","volume":"8","author":"C Junghanss","year":"2002","unstructured":"Junghanss C, Marr KA, Carter RA, et al.: Incidence and outcome of bacterial and fungal infections following nonmyeloablative compared with myeloablative allogeneic hematopoietic stem cell transplantation: a matched control study. Biol Blood Marrow Transplant 2002, 8:512\u2013520.","journal-title":"Biol Blood Marrow Transplant"},{"key":"10_CR24","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1097\/00001432-200208000-00001","volume":"15","author":"C Junghanss","year":"2002","unstructured":"Junghanss C, Marr KA: Infectious risks and outcomes after stem cell transplantation: are nonmyeloablative transplants changing the picture?\n                           Curr Opin Infect Dis 2002, 15:347\u2013353.","journal-title":"Curr Opin Infect Dis"},{"key":"10_CR25","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1038\/sj.bmt.1704684","volume":"34","author":"KB Robertson","year":"2004","unstructured":"Robertson KB, Barron MA, Nieto Y: West Nile virus infection in bone marrow transplant patients. Bone Marrow Transplant 2004, 34:823\u2013824.","journal-title":"Bone Marrow Transplant"},{"key":"10_CR26","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1097\/00019052-200406000-00016","volume":"17","author":"KL Roos","year":"2004","unstructured":"Roos KL: West Nile encephalitis and myelitis. Curr Opin Neurol 2004, 17:343\u2013346.","journal-title":"Curr Opin Neurol"},{"key":"10_CR27","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1111\/j.1399-0012.2004.00283.x","volume":"18","author":"H Wadei","year":"2004","unstructured":"Wadei H, Alangaden GJ, Sillix DH, et al.: West Nile virus encephalitis: an emerging disease in renal transplant recipients. Clin Transplant 2004, 18:753\u2013758.","journal-title":"Clin Transplant"},{"key":"10_CR28","first-page":"1","volume":"49","author":"Centers for Disease Control and Prevention","year":"2000","unstructured":"Centers for Disease Control and Prevention: Guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients: recommendations of CDC, the Infectious Disease Society of America, and the American Society of Blood and Marrow Transplantation. MMWR Morb Mortal Wkly Rep 2000, 49:1\u201328.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10_CR29","first-page":"24","volume":"18","author":"K Marr","year":"2004","unstructured":"Marr K: Combination antifungal therapy: where are we now, and where are we going?\n                           Oncology (Williston Park) 2004, 18:24\u201329.","journal-title":"Oncology (Williston Park)"},{"key":"10_CR30","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1086\/423380","volume":"39","author":"KA Marr","year":"2004","unstructured":"MarrKA, Boeckh M, Carter RA, et al.: Combination antifungal therapy for invasive aspergillosis. Clin Infect Dis 2004, 39:797\u2013802. This small retrospective study found that patients on combination antifungal therapy had better survival than those on monotherapy.","journal-title":"Clin Infect Dis"},{"key":"10_CR31","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1086\/313618","volume":"30","author":"Y Ito","year":"2000","unstructured":"Ito Y, Kimura H, Yabuta Y, et al.: Exacerbation of herpes simplex encephalitis after successful treatment with acyclovir. Clin Infect Dis 2000, 30:185\u2013187.","journal-title":"Clin Infect Dis"},{"key":"10_CR32","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1111\/j.1468-1331.2005.01126.x","volume":"12","author":"I Steiner","year":"2005","unstructured":"Steiner I, Budka H, Chaudhuri A, et al.: Viral encephalitis: a review of diagnostic methods and guidelines for management. Eur J Neurol 2005, 12:331\u2013343.","journal-title":"Eur J Neurol"},{"issue":"Suppl 1","key":"10_CR33","doi-asserted-by":"publisher","first-page":"i10","DOI":"10.1136\/jnnp.2003.034280","volume":"75","author":"PG Kennedy","year":"2004","unstructured":"Kennedy PG: Viral encephalitis: causes, differential diagnosis, and management. J Neurol Neurosurg Psychiatry 2004, 75(Suppl 1):i10-i15. This review details the considerations in diagnosing and treating viral encephalitis.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10_CR34","unstructured":"2005 Drug Topics Red Book. Edited by Fleming T. Montvale, NJ: Medical Economics Co.; 2005:864."},{"issue":"Suppl 1","key":"10_CR35","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1093\/jac\/49.suppl_1.31","volume":"49","author":"B Dupont","year":"2002","unstructured":"Dupont B: Overview of the lipid formulations of amphotericin B. J Antimicrob Chemother 2002, 49(Suppl 1):31\u201336.","journal-title":"J Antimicrob Chemother"},{"key":"10_CR36","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1086\/315643","volume":"182","author":"AH Groll","year":"2000","unstructured":"Groll AH, Giri N, Petraitis V, et al.: Comparative efficacy and distribution of lipid formulations of amphotericin B in experimental Candida albicans infection of the central nervous system. J Infect Dis 2000, 182:274\u2013282.","journal-title":"J Infect Dis"},{"key":"10_CR37","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1016\/S0149-2918(03)80126-1","volume":"25","author":"L Jeu","year":"2003","unstructured":"Jeu L, Piacenti FJ, Lyakhovetskiy AG, et al.: Voriconazole. Clin Ther 2003, 25:1321\u20131381.","journal-title":"Clin Ther"},{"key":"10_CR38","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/s10096-003-0934-2","volume":"22","author":"V de Lastours","year":"2003","unstructured":"de LastoursV, Lefort A, Zappa M, et al.: Two cases of cerebral aspergillosis successfully treated with voriconazole. Eur J Clin Microbiol Infect Dis 2003, 22:297\u2013299.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10_CR39","first-page":"ECR05","volume":"88","author":"L Marbello","year":"2003","unstructured":"Marbello L, Nosari A, Carrafiello G, et al.: Successful treatment with voriconazole of cerebral aspergillosis in an hematologic patient. Haematologica 2003, 88:ECR05.","journal-title":"Haematologica"},{"issue":"Suppl 1","key":"10_CR40","first-page":"S42","volume":"83","author":"S Schwartz","year":"2004","unstructured":"Schwartz S, Thiel E: Update on the treatment of cerebral aspergillosis. Ann Hematol 2004, 83(Suppl 1):S42-S44. This brief report describes the CSF and brain penetration of antifungals and reviews the literature on treatment of cerebral aspergillosis.","journal-title":"Ann Hematol"},{"key":"10_CR41","doi-asserted-by":"publisher","first-page":"4867","DOI":"10.1128\/AAC.49.12.4867-4875.2005","volume":"49","author":"KV Clemons","year":"2005","unstructured":"Clemons KV, Espiritu M, Parmar R, Stevens DA: Comparative efficacies of conventional amphotericin B, liposomal amphotericin B (AmBisome), caspofungin, micafungin, and voriconazole alone and in combination against experimental murine central nervous system aspergillosis. Antimicrob Agents Chemother 2005, 49:4867\u20134875.","journal-title":"Antimicrob Agents Chemother"},{"key":"10_CR42","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1034\/j.1399-3062.2002.02005.x","volume":"4","author":"JE Julin","year":"2002","unstructured":"Julin JE, van Burik JH, Krivit W, et al.: Ganciclovir-resistant cytomegalovirus encephalitis in a bone marrow transplant recipient. Transplant Infect Dis 2002, 4:201\u2013206.","journal-title":"Transplant Infect Dis"},{"key":"10_CR43","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/S1386-6532(99)00065-7","volume":"16","author":"WG Nichols","year":"2000","unstructured":"Nichols WG, Boeckh M: Recent advances in the therapy and prevention of CMV infection. J Clin Virol 2000, 16:25\u201340.","journal-title":"J Clin Virol"},{"key":"10_CR44","first-page":"304","volume":"14","author":"SM Kayacan","year":"2001","unstructured":"Kayacan SM, Turkmen A, Alis H, et al.: Successful therapy combined with surgery for severe post-transplant nocardiosis. J Nephrol 2001, 14:304\u2013306.","journal-title":"J Nephrol"},{"key":"10_CR45","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.surneu.2004.04.020","volume":"63","author":"A Dubey","year":"2005","unstructured":"Dubey A, Patwardhan RV, Sampth S, et al.: Intracranial fungal granuloma: analysis of 40 patients and review of the literature. Surg Neurol 2005, 63:254\u2013260.","journal-title":"Surg Neurol"},{"key":"10_CR46","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1111\/j.1439-0507.2005.01167.x","volume":"48","author":"C Sundaram","year":"2005","unstructured":"Sundaram C, Mahadevan A, Laxmi V, et al.: Cerebral zygomycosis. Mycoses 2005, 48:396\u2013407.","journal-title":"Mycoses"},{"key":"10_CR47","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1086\/380635","volume":"38","author":"SG Revankar","year":"2004","unstructured":"Revankar SG, Sutton DA, Rinaldi MG: Primary central nervous system phaeohyphomycosis: a review of 101 cases. Clin Infect Dis 2004, 38:206\u2013216.","journal-title":"Clin Infect Dis"},{"key":"10_CR48","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1097\/00001432-200412000-00004","volume":"17","author":"HM Al-Abdely","year":"2004","unstructured":"Al-Abdely HM: Management of rare fungal infections. Curr Opin Infect Dis 2004, 17:527\u2013532.","journal-title":"Curr Opin Infect Dis"},{"key":"10_CR49","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1016\/S1473-3099(05)70297-8","volume":"5","author":"HA Torres","year":"2005","unstructured":"Torres HA, Hachem RY, Chemaly RF, et al.: Posaconazole: a broad-spectrum triazole antifungal. Lancet Infect Dis 2005, 5:775\u2013785.","journal-title":"Lancet Infect Dis"},{"key":"10_CR50","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1093\/jac\/dki288","volume":"56","author":"P Pitisuttithum","year":"2005","unstructured":"Pitisuttithum P, Negroni R, Graybill JR, et al.: Activity of posaconazole in the treatment of central nervous system fungal infections. J Antimicrob Chemother 2005, 56:745\u2013755.","journal-title":"J Antimicrob Chemother"},{"key":"10_CR51","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.1086\/430068","volume":"40","author":"BH Segal","year":"2005","unstructured":"Segal BH, Barnhart LA, Anderson VL, et al.: Posaconazole as salvage therapy in patients with chronic granulomatous disease and invasive filamentous fungal infection. Clin Infect Dis 2005, 40:1684\u20131688.","journal-title":"Clin Infect Dis"}],"container-title":["Current Treatment Options in Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11940-006-0010-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11940-006-0010-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11940-006-0010-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11940-006-0010-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,29]],"date-time":"2022-07-29T11:53:43Z","timestamp":1659095623000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11940-006-0010-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,5]]},"references-count":51,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2006,5]]}},"alternative-id":["10"],"URL":"https:\/\/doi.org\/10.1007\/s11940-006-0010-1","relation":{},"ISSN":["1092-8480","1534-3138"],"issn-type":[{"value":"1092-8480","type":"print"},{"value":"1534-3138","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,5]]},"assertion":[{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}